REDCARE PHARMACY NV (RDC.DE) Stock Fundamental Analysis
Europe - FRA:RDC - NL0012044747 - Common Stock
63.7 EUR
0 (0%)
RDC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 21 industry peers in the Consumer Staples Distribution & Retail industry. The financial health of RDC is average, but there are quite some concerns on its profitability. While showing a medium growth rate, RDC is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year RDC has reported negative net income.
In the past year RDC had a positive cash flow from operations.
In the past 5 years RDC always reported negative net income.
Of the past 5 years RDC 4 years had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -2.88%, RDC is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
RDC's Return On Equity of -7.01% is on the low side compared to the rest of the industry. RDC is outperformed by 80.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.88% | ||
| ROE | -7.01% | ||
| ROIC | N/A |
ROA(3y)-5.45%
ROA(5y)-5.79%
ROE(3y)-11.19%
ROE(5y)-11.08%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
RDC has a Gross Margin (22.88%) which is in line with its industry peers.
In the last couple of years the Gross Margin of RDC has grown nicely.
The Profit Margin and Operating Margin are not available for RDC so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.88% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.88%
GM growth 5Y3.23%
2. Health
2.1 Basic Checks
RDC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RDC has less shares outstanding
The number of shares outstanding for RDC has been increased compared to 5 years ago.
The debt/assets ratio for RDC is higher compared to a year ago.
2.2 Solvency
RDC has an Altman-Z score of 3.30. This indicates that RDC is financially healthy and has little risk of bankruptcy at the moment.
RDC's Altman-Z score of 3.30 is fine compared to the rest of the industry. RDC outperforms 66.67% of its industry peers.
A Debt/Equity ratio of 0.62 indicates that RDC is somewhat dependend on debt financing.
RDC has a Debt to Equity ratio of 0.62. This is in the better half of the industry: RDC outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.3 |
ROIC/WACCN/A
WACC6.74%
2.3 Liquidity
RDC has a Current Ratio of 1.68. This is a normal value and indicates that RDC is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Current ratio value of 1.68, RDC belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
A Quick Ratio of 1.23 indicates that RDC should not have too much problems paying its short term obligations.
RDC has a Quick ratio of 1.23. This is amongst the best in the industry. RDC outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.68 | ||
| Quick Ratio | 1.23 |
3. Growth
3.1 Past
The earnings per share for RDC have decreased strongly by -39.61% in the last year.
RDC shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.68%.
RDC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.59% yearly.
EPS 1Y (TTM)-39.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.47%
Revenue 1Y (TTM)26.68%
Revenue growth 3Y30.76%
Revenue growth 5Y27.59%
Sales Q2Q%25.18%
3.2 Future
Based on estimates for the next years, RDC will show a very strong growth in Earnings Per Share. The EPS will grow by 52.47% on average per year.
Based on estimates for the next years, RDC will show a quite strong growth in Revenue. The Revenue will grow by 18.66% on average per year.
EPS Next Y49.41%
EPS Next 2Y55.83%
EPS Next 3Y51.95%
EPS Next 5Y52.47%
Revenue Next Year25.61%
Revenue Next 2Y22.72%
Revenue Next 3Y21.15%
Revenue Next 5Y18.66%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for RDC. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 77.21, RDC can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, RDC is valued more expensive than 85.71% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of RDC to the average of the S&P500 Index (22.35), we can say RDC is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 77.21 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RDC indicates a rather expensive valuation: RDC more expensive than 80.95% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 36.44 |
4.3 Compensation for Growth
RDC's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as RDC's earnings are expected to grow with 51.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.83%
EPS Next 3Y51.95%
5. Dividend
5.1 Amount
No dividends for RDC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:RDC (11/6/2025, 10:17:03 AM)
63.7
0 (0%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)
Earnings (Next)
Inst Owners48.6%
Inst Owner ChangeN/A
Ins Owners7.4%
Ins Owner ChangeN/A
Market Cap1.31B
Revenue(TTM)2.82B
Net Income(TTM)-35186000
Analysts78.57
Price Target155.65 (144.35%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-1.55%
Max Revenue beat(2)-1.13%
Revenue beat(4)0
Avg Revenue beat(4)-1.42%
Min Revenue beat(4)-2.24%
Max Revenue beat(4)-0.77%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.91%
PT rev (3m)-7.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)11.46%
Revenue NQ rev (1m)-0.52%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 77.21 | ||
| P/S | 0.46 | ||
| P/FCF | N/A | ||
| P/OCF | 39.95 | ||
| P/B | 2.61 | ||
| P/tB | 13.16 | ||
| EV/EBITDA | 36.44 |
EPS(TTM)-1.8
EYN/A
EPS(NY)0.83
Fwd EY1.3%
FCF(TTM)-2.99
FCFYN/A
OCF(TTM)1.59
OCFY2.5%
SpS137.07
BVpS24.41
TBVpS4.84
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.88% | ||
| ROE | -7.01% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.88% | ||
| FCFM | N/A |
ROA(3y)-5.45%
ROA(5y)-5.79%
ROE(3y)-11.19%
ROE(5y)-11.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.88%
GM growth 5Y3.23%
F-Score3
Asset Turnover2.31
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 8.5 | ||
| Cap/Depr | 136.74% | ||
| Cap/Sales | 3.34% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 90.05% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.68 | ||
| Quick Ratio | 1.23 | ||
| Altman-Z | 3.3 |
F-Score3
WACC6.74%
ROIC/WACCN/A
Cap/Depr(3y)87.99%
Cap/Depr(5y)151.24%
Cap/Sales(3y)2.78%
Cap/Sales(5y)3.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.47%
EPS Next Y49.41%
EPS Next 2Y55.83%
EPS Next 3Y51.95%
EPS Next 5Y52.47%
Revenue 1Y (TTM)26.68%
Revenue growth 3Y30.76%
Revenue growth 5Y27.59%
Sales Q2Q%25.18%
Revenue Next Year25.61%
Revenue Next 2Y22.72%
Revenue Next 3Y21.15%
Revenue Next 5Y18.66%
EBIT growth 1Y-72.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year303.27%
EBIT Next 3Y97.51%
EBIT Next 5Y68.49%
FCF growth 1Y-2656.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18.32%
OCF growth 3Y23.87%
OCF growth 5YN/A
REDCARE PHARMACY NV / RDC.DE FAQ
Can you provide the ChartMill fundamental rating for REDCARE PHARMACY NV?
ChartMill assigns a fundamental rating of 3 / 10 to RDC.DE.
What is the valuation status of REDCARE PHARMACY NV (RDC.DE) stock?
ChartMill assigns a valuation rating of 1 / 10 to REDCARE PHARMACY NV (RDC.DE). This can be considered as Overvalued.
Can you provide the profitability details for REDCARE PHARMACY NV?
REDCARE PHARMACY NV (RDC.DE) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for RDC stock?
The Earnings per Share (EPS) of REDCARE PHARMACY NV (RDC.DE) is expected to grow by 49.41% in the next year.